Probenecid pretreatment enhances anticonvulsant action of NBQX in mice
- 17 March 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 213 (1) , 151-153
- https://doi.org/10.1016/0014-2999(92)90247-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsyEuropean Journal of Pharmacology, 1991
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- Excitatory postsynaptic potentials in rat neocortical neurons in vitro. III. Effects of a quinoxalinedione non-NMDA receptor antagonistJournal of Neurophysiology, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor AntagonistsScience, 1988
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981
- Antiepileptic Drug Development: II. Anticonvulsant Drug ScreeningEpilepsia, 1978
- A new device for the rapid measurement of impaired motor function in micePharmacology Biochemistry and Behavior, 1977